BD Diagnostics and Lab21 are to collaborate to develop oncology assays for the BD MAX fully automated bench-top molecular system. Under the terms of the collaboration, Lab21 will develop polymerase chain reaction-based assays on the BD MAX platform for a series of oncology markers, while BD will be responsible for manufacturing and commercialising the tests worldwide.
HORIBA Medical is a renowned specialist in the design and manufacture of automated in-vitro diagnostic systems for analysis in haematology, clinical chemistry, and haemostasis. From compact point of care (POC) solutions to high throughput laboratory systems, HORIBA Medical has successfully developed an array of analysers and data management...
RAF Museum, Hendon, London NW9 5LL
15 May, 2025
Royal College Of Physicians Of Edinburgh
15 May, 2025
Jubilee Hotel and Conference Centre, Nottingham, UK
15 May, 2025
Online
21 May 2025
Online
9 June 2025
